FC
MRK icon

Farringdon Capital’s Merck MRK Stock Holding History

Farringdon Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
9,120
-12,927
-59% -$1.49M 0.24% 125
2025
Q4 		$2.32M Buy
+22,047
New +$2.07M 0.57% 41
2025
Q2 		– Sell
-2,364
Closed -$212K – 535
2025
Q1 		$212K Buy
+2,364
New +$221K 0.11% 279

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Farringdon Capital's MRK Position: Q1 2026 in Review

Farringdon Capital reduced its Merck (MRK) stake by 59% in Q1 2026, selling an estimated $1.49M and leaving 9,120 shares worth $1.1M. The position accounts for 0.24% of the portfolio, ranked #125.

Farringdon Capital first reported a position in MRK in Q1 2025 and has held it in 3 quarters since. The position peaked at $2.32M in Q4 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Farringdon Capital held 9,120 shares of Merck worth $1.1M as of Q1 2026.
  • Farringdon Capital sold 12,927 Merck shares in Q1 2026, an estimated $1.49M.
  • Merck made up 0.24% of Farringdon Capital's portfolio in Q1 2026, its #125 holding.
  • Farringdon Capital first reported a position in Merck in Q1 2025 and has held it in 3 quarters since.
  • Farringdon Capital's Merck position peaked at $2.32M in Q4 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.